{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T18:52:37Z","timestamp":1789584757455,"version":"build-2803163510"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T00:00:00Z","timestamp":1702598400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T00:00:00Z","timestamp":1702598400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Brain Tumor Pathol"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s10014-023-00471-8","type":"journal-article","created":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T16:02:37Z","timestamp":1702656157000},"page":"18-29","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["A rare case of primary central nervous system histiocytic sarcoma harboring a novel ARHGAP45::BRAF fusion: a case report and literature review"],"prefix":"10.1007","volume":"41","author":[{"given":"Luyi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzhi","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hangyu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,15]]},"reference":[{"issue":"2","key":"471_CR1","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1182\/blood-2017-10-812495","volume":"131","author":"A Kommalapati","year":"2018","unstructured":"Kommalapati A et al (2018) Histiocytic sarcoma: a population-based analysis of incidence, demographic disparities, and long-term outcomes. Blood 131(2):265\u2013268","journal-title":"Blood"},{"issue":"5","key":"471_CR2","doi-asserted-by":"publisher","first-page":"650","DOI":"10.5858\/arpa.2018-0349-RS","volume":"144","author":"YP Hung","year":"2020","unstructured":"Hung YP, Qian X (2020) Histiocytic Sarcoma. Arch Pathol Lab Med 144(5):650\u2013654","journal-title":"Arch Pathol Lab Med"},{"issue":"7","key":"471_CR3","doi-asserted-by":"publisher","first-page":"6749","DOI":"10.1158\/1538-7445.AM2023-6749","volume":"83","author":"D Keerty","year":"2023","unstructured":"Keerty D, Haddad PA (2023) Histiocytic sarcoma descriptors and clinicopathologic determinants of survival: Analysis of a pooled database. Cancer Res 83(7):6749\u20136749","journal-title":"Cancer Res"},{"issue":"6","key":"471_CR4","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1111\/neup.12396","volume":"37","author":"YH Kim","year":"2017","unstructured":"Kim YH et al (2017) Pediatric intracerebral histiocytic sarcoma with rhabdoid features: Case report and literature review. Neuropathology 37(6):560\u2013568","journal-title":"Neuropathology"},{"issue":"1","key":"471_CR5","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s13014-018-1115-x","volume":"13","author":"JM May","year":"2018","unstructured":"May JM et al (2018) Primary histiocytic sarcoma of the central nervous system: a case report with platelet derived growth factor receptor mutation and PD-L1\/PD-L2 expression and literature review. Radiat Oncol 13(1):167","journal-title":"Radiat Oncol"},{"key":"471_CR6","doi-asserted-by":"publisher","first-page":"300664","DOI":"10.1016\/j.hpr.2022.300664","volume":"29","author":"R Uno","year":"2022","unstructured":"Uno R et al (2022) A case of primary histiocytic sarcoma of the central nervous system. Hum Pathol Rep 29:300664","journal-title":"Hum Pathol Rep"},{"issue":"16","key":"471_CR7","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1016\/j.ejca.2015.06.109","volume":"51","author":"M Gounder","year":"2015","unstructured":"Gounder M et al (2015) Impact of surgery, radiation and systemic therapy on the outcomes of patients with dendritic cell and histiocytic sarcomas. Eur J Cancer 51(16):2413\u20132422","journal-title":"Eur J Cancer"},{"issue":"4","key":"471_CR8","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s40272-023-00569-8","volume":"25","author":"AV Geerlinks","year":"2023","unstructured":"Geerlinks AV, Abla O (2023) Treatment of Langerhans Cell Histiocytosis and Histiocytic Disorders: A Focus on MAPK Pathway Inhibitors. Paediatr Drugs 25(4):399\u2013409","journal-title":"Paediatr Drugs"},{"issue":"17","key":"471_CR9","doi-asserted-by":"publisher","first-page":"4264","DOI":"10.3390\/cancers14174264","volume":"14","author":"D Talloa","year":"2022","unstructured":"Talloa D et al (2022) BRAF and MEK Targeted Therapies in Pediatric Central Nervous System Tumors. Cancers (Basel) 14(17):4264","journal-title":"Cancers (Basel)"},{"issue":"8","key":"471_CR10","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN et al (2021) The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol 23(8):1231\u20131251","journal-title":"Neuro Oncol"},{"key":"471_CR11","first-page":"684","volume":"62","author":"P Zuo","year":"2023","unstructured":"Zuo P et al (2023) Primary intracranial histiocytic sarcomas: a report of six cases and a pooled analysis of individual patient data. J Cancer Res Clin Oncol 62:684","journal-title":"J Cancer Res Clin Oncol"},{"issue":"3","key":"471_CR12","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3171\/2013.6.PEDS12533","volume":"12","author":"RO Almefty","year":"2013","unstructured":"Almefty RO et al (2013) Primary histiocytic sarcoma of the brain mimicking cerebral abscess. J Neurosurg Pediatr 12(3):251\u2013257","journal-title":"J Neurosurg Pediatr"},{"issue":"6","key":"471_CR13","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.humpath.2012.11.002","volume":"44","author":"W Wu","year":"2013","unstructured":"Wu W et al (2013) Primary central nervous system histiocytic sarcoma presenting as a postradiation sarcoma: case report and literature review. Hum Pathol 44(6):1177\u20131183","journal-title":"Hum Pathol"},{"issue":"1","key":"471_CR14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3121\/cmr.2012.1092","volume":"11","author":"S Chalasani","year":"2013","unstructured":"Chalasani S et al (2013) Unusual presentation of a rare cancer: histiocytic sarcoma in the brain 16 years after treatment for acute lymphoblastic leukemia. Clin Med Res 11(1):31\u201335","journal-title":"Clin Med Res"},{"key":"471_CR15","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/1752-1947-7-127","volume":"7","author":"E Perez-Ruiz","year":"2013","unstructured":"Perez-Ruiz E et al (2013) Primary leptomeningeal histiocytic sarcoma in a patient with a good outcome: a case report and review of the literature. J Med Case Rep 7:127","journal-title":"J Med Case Rep"},{"issue":"3","key":"471_CR16","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1007\/s10014-012-0123-z","volume":"30","author":"Y Laviv","year":"2013","unstructured":"Laviv Y, Zagzag D, Fichman-Horn S, Michowitz S (2013) Primary central nervous system histiocytic sarcoma. Brain Tumor Pathol 30(3):192\u2013195","journal-title":"Brain Tumor Pathol"},{"issue":"16","key":"471_CR17","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1212\/WNL.0000000000000880","volume":"83","author":"A Idbaih","year":"2014","unstructured":"Idbaih A et al (2014) Dramatic response of a BRAF V600E-mutated primary CNS histiocytic sarcoma to vemurafenib. Neurology 83(16):1478\u20131480","journal-title":"Neurology"},{"key":"471_CR18","doi-asserted-by":"publisher","first-page":"bcr2014204663","DOI":"10.1136\/bcr-2014-204663","volume":"2014","author":"A Moulignier","year":"2014","unstructured":"Moulignier A, Mikol J, Heran F, Galicier L (2014) Isolated III cranial nerve palsies may point to primary histiocytic sarcoma. BMJ Case Rep 2014:bcr2014204663","journal-title":"BMJ Case Rep"},{"issue":"6","key":"471_CR19","doi-asserted-by":"publisher","first-page":"684","DOI":"10.4103\/0028-3886.149409","volume":"62","author":"J Bai","year":"2014","unstructured":"Bai J et al (2014) Primary central nervous system histiocytic sarcoma mimicking glioma. Neurol India 62(6):684\u2013685","journal-title":"Neurol India"},{"issue":"1","key":"471_CR20","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s10014-014-0191-3","volume":"32","author":"CJ Chen","year":"2015","unstructured":"Chen CJ et al (2015) Histiocytic sarcoma of the cavernous sinus: case report and literature review. Brain Tumor Pathol 32(1):66\u201371","journal-title":"Brain Tumor Pathol"},{"issue":"12","key":"471_CR21","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1007\/s00381-015-2815-2","volume":"31","author":"M Foster","year":"2015","unstructured":"Foster M et al (2015) Primary cerebral histiocytic sarcoma in childhood: a case report of protracted survival and review of the literature. Childs Nerv Syst 31(12):2363\u20132368","journal-title":"Childs Nerv Syst"},{"issue":"12","key":"471_CR22","first-page":"1120","volume":"74","author":"AF Brown","year":"2015","unstructured":"Brown AF et al (2015) Primary Central Nervous System Histiocytic Sarcoma Arising After Precursor B-Cell Acute Lymphoblastic Leukemia. J Neuropathol Exp Neurol 74(12):1120\u20131126","journal-title":"J Neuropathol Exp Neurol"},{"issue":"3","key":"471_CR23","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/bpa.12260","volume":"25","author":"MB Nieuwenhuis","year":"2015","unstructured":"Nieuwenhuis MB et al (2015) A 43-Year-Old Female with Multifocal Cerebral Lesions. Histiocytic Sarcoma Brain Pathol 25(3):371\u2013372","journal-title":"Histiocytic Sarcoma Brain Pathol"},{"issue":"2","key":"471_CR24","doi-asserted-by":"publisher","first-page":"322","DOI":"10.4143\/crt.2013.163","volume":"47","author":"H So","year":"2015","unstructured":"So H et al (2015) Primary histiocytic sarcoma of the central nervous system. Cancer Res Treat 47(2):322\u2013328","journal-title":"Cancer Res Treat"},{"issue":"11","key":"471_CR25","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1007\/s10072-016-2636-4","volume":"37","author":"T Ueno","year":"2016","unstructured":"Ueno T et al (2016) An unusual case of chronic meningitis due to histiocytic sarcoma of the central nervous system with meningeal dissemination. Neurol Sci 37(11):1875\u20131877","journal-title":"Neurol Sci"},{"issue":"8","key":"471_CR26","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.3109\/10428194.2015.1120867","volume":"57","author":"RC Curry","year":"2016","unstructured":"Curry RC et al (2016) High-dose methotrexate-based chemotherapy as treatment for histiocytic sarcoma of the central nervous system. Leuk Lymphoma 57(8):1961\u20131964","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"471_CR27","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/neup.12390","volume":"37","author":"M Zanelli","year":"2017","unstructured":"Zanelli M et al (2017) Primary histiocytic sarcoma presenting as diffuse leptomeningeal disease: Case description and review of the literature. Neuropathology 37(6):517\u2013525","journal-title":"Neuropathology"},{"key":"471_CR28","doi-asserted-by":"publisher","first-page":"1053e1","DOI":"10.1016\/j.wneu.2017.07.001","volume":"106","author":"W Clifton","year":"2017","unstructured":"Clifton W et al (2017) Infection or Glioma? The False Dilemma of Primary Central Nervous System Histiocytic Sarcoma. World Neurosurg 106:1053e1-1053e5","journal-title":"World Neurosurg"},{"issue":"6","key":"471_CR29","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/neup.12510","volume":"38","author":"E Takahashi","year":"2018","unstructured":"Takahashi E, Sakakibara A, Tsuzuki T, Nakamura S (2018) Case of primary central nervous system histiocytic sarcoma with prominent proliferation of histiocytic cells between the trabeculae of reactive glial cells. Neuropathology 38(6):609\u2013618","journal-title":"Neuropathology"},{"issue":"26","key":"471_CR30","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000011271","volume":"97","author":"S Ma","year":"2018","unstructured":"Ma S et al (2018) Primary central nervous system histiocytic sarcoma: A case report and review of literature. Medicine (Baltimore) 97(26):e11271","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"471_CR31","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/nan.12490","volume":"45","author":"F Marguet","year":"2019","unstructured":"Marguet F et al (2019) Molecular characteristics of multifocal brain histiocytic sarcoma. Neuropathol Appl Neurobiol 45(3):309\u2013313","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"1","key":"471_CR32","doi-asserted-by":"publisher","DOI":"10.1136\/bmjno-2021-000147","volume":"3","author":"M Silsby","year":"2021","unstructured":"Silsby M, Varikatt W, Vucic S, Menon P (2021) New onset headache caused by histiocytic sarcoma of the spinal cord and leptomeninges: a case report. BMJ Neurol Open 3(1):e000147","journal-title":"BMJ Neurol Open"},{"issue":"9","key":"471_CR33","doi-asserted-by":"publisher","first-page":"10095","DOI":"10.21037\/apm-21-2117","volume":"10","author":"Y Tian","year":"2021","unstructured":"Tian Y et al (2021) ALK-positive histiocytosis with disseminated disease responded to alectinib: a case report. Ann Palliat Med 10(9):10095\u201310101","journal-title":"Ann Palliat Med"},{"issue":"6","key":"471_CR34","doi-asserted-by":"publisher","first-page":"253","DOI":"10.5414\/NP301473","volume":"41","author":"W Wang","year":"2022","unstructured":"Wang W et al (2022) Primary central nervous system histiocytic sarcoma with somatic NF2 mutation: Case report and review of literature. Clin Neuropathol 41(6):253\u2013262","journal-title":"Clin Neuropathol"},{"issue":"10","key":"471_CR35","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1177\/13524585221097564","volume":"28","author":"DS Rogawski","year":"2022","unstructured":"Rogawski DS et al (2022) A rare neuromyelitis optica mimic: Primary CNS histiocytic sarcoma. Mult Scler 28(10):1651\u20131654","journal-title":"Mult Scler"},{"key":"471_CR36","doi-asserted-by":"publisher","first-page":"101522","DOI":"10.1016\/j.inat.2022.101522","volume":"28","author":"K Negishi","year":"2022","unstructured":"Negishi K et al (2022) Primary histiocytic sarcoma of the central nervous system: A case report. Interdiscip Neurosurg 28:101522","journal-title":"Interdiscip Neurosurg"},{"issue":"5","key":"471_CR37","volume":"14","author":"S Shahrokh","year":"2022","unstructured":"Shahrokh S et al (2022) Successful Treatment of Central Nervous System Histiocytic Sarcoma With Craniectomy and Adjuvant Radiotherapy. Cureus 14(5):e24690","journal-title":"Cureus"},{"issue":"1","key":"471_CR38","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1093\/jnen\/nlab107","volume":"81","author":"CP Onyenekwu","year":"2022","unstructured":"Onyenekwu CP et al (2022) Diffuse Leptomeningeal Histiocytic Sarcoma: Histologic and Molecular Findings in an Autopsy Case. J Neuropathol Exp Neurol 81(1):79\u201381","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"471_CR39","doi-asserted-by":"publisher","first-page":"74","DOI":"10.5414\/NP301400","volume":"41","author":"I Perez","year":"2022","unstructured":"Perez I et al (2022) Primary histiocytic sarcoma of the clivus with focal extension into central nervous system and neurologic manifestations: First description at an unusual site with an overwhelming and rapid progression. Clin Neuropathol 41(2):74\u201382","journal-title":"Clin Neuropathol"},{"issue":"3","key":"471_CR40","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.4103\/0028-3886.349657","volume":"70","author":"M Rajeshwari","year":"2022","unstructured":"Rajeshwari M et al (2022) Primary Histiocytic Sarcoma of Brain-Illustration of Two Cases with Varied Histomorphological Features. Neurol India 70(3):1254\u20131259","journal-title":"Neurol India"},{"issue":"11","key":"471_CR41","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201911131","volume":"12","author":"TG Grunewald","year":"2020","unstructured":"Grunewald TG et al (2020) Sarcoma treatment in the era of molecular medicine. EMBO Mol Med 12(11):e11131","journal-title":"EMBO Mol Med"},{"issue":"6","key":"471_CR42","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1038\/s41379-018-0200-x","volume":"32","author":"V Shanmugam","year":"2019","unstructured":"Shanmugam V et al (2019) Identification of diverse activating mutations of the RAS-MAPK pathway in histiocytic sarcoma. Mod Pathol 32(6):830\u2013843","journal-title":"Mod Pathol"},{"issue":"4","key":"471_CR43","doi-asserted-by":"publisher","first-page":"951","DOI":"10.3324\/haematol.2019.230375","volume":"105","author":"C Egan","year":"2020","unstructured":"Egan C et al (2020) Genomic profiling of primary histiocytic sarcoma reveals two molecular subgroups. Haematologica 105(4):951\u2013960","journal-title":"Haematologica"},{"issue":"2","key":"471_CR44","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00428-016-1965-2","volume":"469","author":"Q Liu","year":"2016","unstructured":"Liu Q et al (2016) Somatic mutations in histiocytic sarcoma identified by next generation sequencing. Virchows Arch 469(2):233\u2013241","journal-title":"Virchows Arch"},{"issue":"22","key":"471_CR45","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1182\/blood.2019003507","volume":"135","author":"G Goyal","year":"2020","unstructured":"Goyal G et al (2020) Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era. Blood 135(22):1929\u20131945","journal-title":"Blood"},{"key":"471_CR46","doi-asserted-by":"publisher","unstructured":"Zarnegar S et al (2018) Novel activating BRAF fusion identifies a recurrent alternative mechanism for ERK activation in pediatric Langerhans cell histiocytosis. Pediatr Blood Cancer 65(1). https:\/\/doi.org\/10.1002\/pbc.26699","DOI":"10.1002\/pbc.26699"},{"issue":"6","key":"471_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28933","volume":"68","author":"P Jain","year":"2021","unstructured":"Jain P et al (2021) BRAF fusions in pediatric histiocytic neoplasms define distinct therapeutic responsiveness to RAF paradox breakers. Pediatr Blood Cancer 68(6):e28933","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"471_CR48","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41408-022-00693-7","volume":"12","author":"S Zanwar","year":"2022","unstructured":"Zanwar S et al (2022) Clinical and therapeutic implications of BRAF fusions in histiocytic disorders. Blood Cancer J 12(6):97","journal-title":"Blood Cancer J"},{"issue":"12","key":"471_CR49","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1007\/s12094-022-02916-6","volume":"24","author":"MD Fenor","year":"2022","unstructured":"Fenor MD et al (2022) MEK inhibitor sensitivity in BRAF fusion-driven prostate cancer. Clin Transl Oncol 24(12):2432\u20132440","journal-title":"Clin Transl Oncol"},{"key":"471_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.945620","volume":"12","author":"Y Yu","year":"2022","unstructured":"Yu Y et al (2022) Rapid response to monotherapy with MEK inhibitor trametinib for a lung adenocarcinoma patient harboring primary SDN1-BRAF fusion: A case report and literature review. Front Oncol 12:945620","journal-title":"Front Oncol"},{"issue":"1","key":"471_CR51","doi-asserted-by":"publisher","first-page":"373","DOI":"10.21873\/anticanres.15495","volume":"42","author":"A Domen","year":"2022","unstructured":"Domen A et al (2022) Excellent Response to MEK Inhibition in an AGK-BRAF Gene Fusion Driven Carcinoma: Case Report and Literature Review. Anticancer Res 42(1):373\u2013379","journal-title":"Anticancer Res"},{"issue":"12","key":"471_CR52","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1038\/s41591-019-0653-6","volume":"25","author":"BH Durham","year":"2019","unstructured":"Durham BH et al (2019) Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms. Nat Med 25(12):1839\u20131842","journal-title":"Nat Med"}],"container-title":["Brain Tumor Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10014-023-00471-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10014-023-00471-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10014-023-00471-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T16:30:57Z","timestamp":1704731457000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10014-023-00471-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,15]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["471"],"URL":"https:\/\/doi.org\/10.1007\/s10014-023-00471-8","relation":{},"ISSN":["1433-7398","1861-387X"],"issn-type":[{"value":"1433-7398","type":"print"},{"value":"1861-387X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,15]]},"assertion":[{"value":"26 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they were no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Ethics Committee of Xi\u2019an Children\u2019s Hospital Affiliated to Xi\u2019an Jiaotong University. Participants provided written consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and informed consent"}}]}}